Medical devices, healthcare technology and the business of care
510(k) clearance · K253800

0909FCE, 0909FCE-HS

Rayence Co., Ltd. · Decision date Jul 31, 2026

FDA DECISIONK253800

What did the FDA decide?

FDA records K253800 as a 510(k) premarket notification, with a decision dated Jul 31, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Jul 31, 2026

FDA source record

Regulatory record facts

Identifier
K253800
Regulatory pathway
510(k) premarket notification
Product code
MQB
Decision code
SESE
Decision date
Jul 31, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Solid State X-Ray Imager (Flat Panel/Digital Imager).

Product code
MQB
FDA device class
2

FDA decision timeline

  1. K253800 received

    Application receipt date recorded by FDA.

  2. K253800 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MQB

Product / regulatory recordCompanyPathwayDecision dateSource
Vieworks Co., Ltd.510(k) clearanceJun 18, 2026FDA
Konica Minolta Healthcare Americas, Inc.510(k) clearanceJun 12, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rayence Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hwaseong-Si

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records